Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-24 @ 2:39 PM
NCT ID:
NCT01145859
Eligibility Criteria:
Inclusion Criteria:
* Pediatric subjects \> 6 months and \< 18 years of age at the time of administration of study drug.
* Patients who have completed treatment of VTE, but are considered to have risk for recurrence of VTE
Exclusion Criteria:
* Any major or clinically relevant bleeding during prior VTE treatment
* Abnormal coagulation tests within 7 days prior to study drug administration
* Severe renal impairment
* Planned invasive procedures prior to or after 24 hours of study drug administration
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
18 Years
Study:
NCT01145859
Study Brief:
Protocol Section:
NCT01145859